|
|
40
|
|
|
B1536
|
|
|
XARELTO 20MG TAB (BSP/COL) RIVAROXABAN
|
|
|
RIVAROXABAN
|
|
|
XARELTO
|
|
|
14'S
|
|
|
C
|
|
|
84.97
|
|
|
6.07
|
|
|
20MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
BSP
|
|
|
BAYER SCHERING PHARMA AG.
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
20120412
|
|
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|